Starting next week, this new feature is likely to be introduced in compliance with the WHO norms
Lacking the means to manufacture their own vaccine in bulk, African countries have so far had to turn to the open market or the Covax scheme
A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received thei
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date